Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
Titel:
Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial
Auteur:
Palmieri, Carlo Linden, Hannah Birrell, Stephen N Wheelwright, Sally Lim, Elgene Schwartzberg, Lee S Dwyer, Amy R Hickey, Theresa E Rugo, Hope S Cobb, Patrick O'Shaughnessy, Joyce A Johnston, Stephen Brufsky, Adam Tilley, Wayne D Overmoyer, Beth
Verschenen in:
Lancet oncology
Paginering:
Jaargang 25 () nr. 3 pagina's 317-325
Jaar:
2024
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license